Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans

Cerebrovasc Dis. 2008;25(1-2):50-8. doi: 10.1159/000111499. Epub 2007 Nov 22.


Background: We have recently shown that ischemic stroke causes a stress-mediator-induced long-lasting immunodepressive state in mice.

Methods: Using head magnetic resonance imaging and standardized immunoassays, we prospectively investigated whether poststroke immunodepression is also seen in humans.

Results: Compared to healthy volunteers (n = 30), a rapid depression of lymphocyte counts and a functional deactivation of monocytes and T helper type 1 cells was observed in acute stroke patients (SP; n = 40). Immunodepression was more pronounced in patients with severe clinical deficit or large infarction. On admission the combination of monocytic tumor necrosis factor alpha release ex vivo and the National Institute of Health Stroke Scale score were the best predictors for nosocomial infection, preferentially affecting older SP.

Conclusion: Our data provide evidence for an immediate suppression of cell-mediated immune responses after ischemic stroke in humans.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Brain Ischemia / complications
  • Brain Ischemia / immunology*
  • Brain Ischemia / pathology
  • Case-Control Studies
  • Cohort Studies
  • Cross Infection / epidemiology*
  • Female
  • Humans
  • Immune Tolerance / physiology*
  • Immunity, Cellular / physiology*
  • Incidence
  • Lymphocyte Count
  • Male
  • Middle Aged
  • Stroke / immunology*
  • Stroke / pathology